The gene expression studies from the in-vitro LRRTM3 knock-down model and human brains, reveal complex correlations between mRNA levels of LRRTM3, CTNNA3, APP and BACE1. These gene and protein interactions may ultimately influence APP metabolism and AD risk. The gene discussed is LRRTM3; the disease is Alzheimer disease.